Online first
Original article
Published online: 2024-05-28
Hypertension in the Polish elderly: Insights into prevalence, awareness, treatment, and control from the NOMED-AF study
Pubmed: 38845421
Abstract
Not available
References
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021; 398(10304): 957–980.
- GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease St. Lancet. 2018; 392(10159): 1923–1994.
- Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010; 303(20): 2043–2050.
- Rahimi K, Mohseni H, Kiran A, et al. Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults. Eur Heart J. 2018; 39(39): 3596–3603.
- Rahimi K, Mohseni H, Otto CM, et al. Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults. PLoS Med. 2017; 14(10): e1002404.
- Emdin CA, Anderson SG, Callender T, et al. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults. BMJ. 2015; 351: h4865.
- Hsu C, McCulloch CE, Darbinian J, et al. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005; 165(8): 923–928.
- Kanno A, Kikuya M, Ohkubo T, et al. Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study. Nephrol Dial Transplant. 2012; 27(8): 3218–3223.
- Emdin CA, Rothwell PM, Salimi-Khorshidi G, et al. Blood pressure and risk of vascular dementia. Stroke. 2016; 47(6): 1429–1435.
- Walker KA, Sharrett AR, Wu A, et al. Association of midlife to late-life blood pressure patterns with incident dementia. JAMA. 2019; 322(6): 535–545.
- Joas E, Bäckman K, Gustafson D, et al. Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension. 2012; 59(4): 796–801.
- Ho JE, Enserro D, Brouwers FP, et al. Predicting heart failure with preserved and reduced ejection fraction. Circ Hear Fail. 2016; 9(6): e003116.
- Kalarus Z, Balsam P, Bandosz P, et al. NOninvasive Monitoring for Early Detection of Atrial Fibrillation: rationale and design of the NOMED-AF study. Kardiol Pol. 2018; 76(10): 1482–1485.
- Kalarus Z, Średniawa B, Mitręga K, et al. Prevalence of atrial fibrillation in the 65 or over Polish population. Report of cross-sectional NOMED-AF study. Kardiol Pol. 2023; 81(1): 14–21.
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104.
- Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension. J Hypertens. 2023; 41(12): 1874–2071.
- Zdrojewski T, Wizner B, Wiecek A, et al. Prevalence, awareness, and control of hypertension in elderly and very elderly in Poland: Results of a cross-sectional representative survey. J Hypertens. 2016; 34(3): 532–538.
- Corrao G, Rea F, Monzio Compagnoni M, et al. Protective effects of antihypertensive treatment in patients aged 85 years or older. J Hypertens. 2017; 35(7): 1432–1441.
- Muntner P, Miles MA, Jaeger BC, et al. Blood pressure control among US adults, 2009 to 2012 through 2017 to 2020. Hypertension. 2022; 79(9): 1971–1980.
- Williams LG, Peacock E, Joyce C, et al. Risk factors for low pharmacy refill adherence among older hypertensive men and women by race. Am J Med Sci. 2018; 356(5): 464–475.
- Madsen TE, Howard G, Kleindorfer DO, et al. Sex differences in and stroke risk in the REGARDS study. Hypertension. 2019; 74(4): 749–755.
- Peters SAE, Carcel C, Millett ERC, et al. Sex differences in the association between major risk factors and the risk of stroke in the UK Biobank cohort study. Neurology. 2020; 95(20): e2715–e2726.
- Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996; 275(20): 1557–1562.
- Dorobantu M, Tautu OF, Dimulescu D, et al. Perspectives on hypertension’s prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey. J Hypertens. 2018; 36(3): 690–700.
- Jarai Z, Nemcsik J, Pall D, et al. Hungarian ambulatory blood pressure monitoring registry revealed that hypertension is highly prevalent both in already diagnosed and treated patients and in suspected hypertensives. J Hypertens. 2023; 41(Suppl 3): e111.
- Neuhauser HK, Adler C, Rosario AS, et al. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–11. J Hum Hypertens. 2015; 29(4): 247–253.
- Muli S, Meisinger C, Heier M, et al. Prevalence, awareness, treatment, and control of hypertension in older people: Results from the population-based KORA-age 1 study. BMC Public Health. 2020; 20(1): 1049.
- Magnussen C, Ojeda FM, Leong DP, et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med. 2023; 389(14): 1273–1285.
